Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04791358 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Decision Impact Trial of KidneyIntelX

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 1, 2024 to Nov 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 1, 2024 to Dec 1, 2026
    • Site details revised
    v7
  2. Primary completion date: Nov 1, 2023 to Nov 1, 2024
    • Study completion date: Dec 1, 2023 to Dec 1, 2024
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: May 1, 2023 to Nov 1, 2023
    • Start date changed from estimate of Sep 1, 2021 to Nov 1, 2021
    • Eligibility criteria expanded, about 6 words
    • Study site revised
  5. Start date: Apr 15, 2021 to Sep 1, 2021v3
  6. Start date: Mar 15, 2021 to Apr 15, 2021v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Renalytix AI, Inc.
4 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
The current trial is designed to evaluate how the results of KidneyIntelX test impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.
Trial Details
NCT Number NCT04791358
Lead Sponsor Renalytix AI, Inc.
Conditions
(from sponsor)		 Diabetic Kidney Disease
Related terms Diabetic Nephropathies
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov